Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Prostatic Neoplasms 10Lung Neoplasms 10Breast Neoplasms 8Pancreatic Neoplasms 5Multiple Myeloma 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Ovarian Neoplasms 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphatic System Neoplasm 4Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Inflammatory Breast Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Pancreatic Ductal Adenocarcinoma 1Obesity 1

Interventions

Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Videotape Recording 1Telemedicine 1Standard of Care 1Specimen Handling 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1Genotype 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hereditary Breast and Ovarian Cancer Syndrome × Specimen Handling × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡